|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.20 BDT | -1.37% |
|
-3.57% | +3.44% |
| Market Cap | 25.48B 206M 181M 168M 155M 290M 19.86B 295M 2B 782M 9.76B 774M 758M 33.76B | P/E 2024 |
68.2x | P/E 2025 | 25.8x |
|---|---|---|---|---|---|
| Enterprise Value | 35.44B 287M 252M 234M 215M 404M 27.63B 410M 2.78B 1.09B 13.58B 1.08B 1.05B 46.96B | EV / Sales 2024 |
4.25x | EV / Sales 2025 | 2.74x |
| Free-Float |
36.94% | Yield 2024 |
1.3% | Yield 2025 | 1.98% |
| 1 day | -1.37% | ||
| 1 week | -3.57% | ||
| Current month | -1.90% | ||
| 1 month | -1.55% | ||
| 3 months | +6.50% | ||
| 6 months | +5.56% | ||
| Current year | +3.44% |
| 1 week | 107.8 |  | 113 |
| 1 month | 107.8 | | 117.9 |
| Current year | 96 | | 117.9 |
| 1 year | 96 | | 147.5 |
| 3 years | 92.4 | | 288.9 |
| 5 years | 92.4 | | 393 |
| 10 years | 16 | | 393 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ulfat Karim
CEO | Chief Executive Officer | - | - |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | - | |
| Director/Board Member | 42 | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.37% | -3.57% | -8.31% | -55.84% | 202M | |
| +0.86% | +1.43% | +48.50% | +160.39% | 1,057B | |
| +1.59% | +4.09% | +55.34% | +53.96% | 624B | |
| +0.95% | +1.91% | +35.91% | +81.14% | 454B | |
| +1.60% | +6.25% | +33.95% | +29.84% | 341B | |
| -0.60% | +1.52% | +35.68% | +39.76% | 297B | |
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 215B | |
| +1.22% | +2.66% | +21.87% | +59.73% | 201B | |
| -1.18% | -3.70% | +14.23% | +66.51% | 162B | |
| Average | +0.20% | +0.96% | +22.51% | +41.13% | 361.42B | |
| Weighted average by Cap. | +0.54% | +1.92% | +35.73% | +77.61% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.7B 86.63M 76.08M 70.76M 64.93M 122M 8.34B 124M 840M 328M 4.1B 325M 318M 14.18B | 12.54B 102M 89.17M 82.93M 76.1M 143M 9.78B 145M 985M 385M 4.81B 381M 373M 16.62B |
| Net income | 521M 4.22M 3.7M 3.44M 3.16M 5.94M 406M 6.03M 40.9M 15.98M 200M 15.83M 15.49M 690M | 947M 7.66M 6.73M 6.26M 5.74M 10.79M 738M 10.96M 74.31M 29.03M 363M 28.76M 28.14M 1.25B |
| Net Debt | 10B 80.92M 71.07M 66.1M 60.65M 114M 7.79B 116M 785M 307M 3.83B 304M 297M 13.25B | 9.96B 80.65M 70.83M 65.87M 60.45M 114M 7.77B 115M 782M 306M 3.82B 303M 296M 13.2B |
Employees
4,771
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | BDT 108.20 | -1.37% | 194,430 |
| 26-07-22 | BDT 109.70 | -0.99% | 213,314 |
| 26-07-21 | BDT 110.80 | +0.64% | 103,673 |
| 26-07-20 | BDT 110.10 | 0.00% | 344,954 |
| 26-07-19 | BDT 110.10 | -1.87% | 503,762 |
- Stock Market
- Stocks
- BEACONPHAR Stock
Select your edition
All financial news and data tailored to specific country editions
